NBIX
Neurocrine Biosciences, Inc.NASDAQHealthcare$131.60-0.72%ClosedMarket Cap: $13.21B
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
65
Sales
87
Buy/Sell Ratio
0.75
Total Bought
$0.00
Total Sold
$2.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Tue Mar 17 | Ratz Andrew | officer: Chief Technical Operations Off | Sell | 0 | $0.00 | 1,018 |
| Tue Mar 17 | Ratz Andrew | officer: Chief Technical Operations Off | Sell | 5,640 | $0.00 | 0 |
| Tue Mar 17 | Ratz Andrew | officer: Chief Technical Operations Off | Sell | 17,724 | $150.10 | 0 |
| Tue Mar 17 | Ratz Andrew | officer: Chief Technical Operations Off | Sell | 805 | $124.12 | 0 |
| Tue Mar 17 | Ratz Andrew | officer: Chief Technical Operations Off | Sell | 31,348 | $124.12 | 0 |
| Tue Mar 17 | Ratz Andrew | officer: Chief Technical Operations Off | Sell | 2,664 | $150.10 | 0 |
| Thu Mar 05 | ABERNETHY MATT | officer: Chief Financial Officer | Sell | 2,249 | $0.00 | 42,808 |
| Mon Feb 23 | Onyia Jude | officer: Chief Scientific Officer | Sell | 3,110 | $0.00 | 25,670 |
| Tue Feb 17 | ABERNETHY MATT | officer: Chief Financial Officer | Sell | 9,968 | $0.00 | 50,259 |
| Tue Feb 17 | ABERNETHY MATT | officer: Chief Financial Officer | Sell | 5,378 | $124.12 | 44,881 |